ICG wins 'attractive' IRR and money multiple with Amolyt sale

ICG invested in Amolyt in January 2023, co-leading the series C round.

9 April 2024•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Featured Europe Healthcare Top Stories